RESUMEN
Kounis syndrome is a rare type of acute coronary syndrome (ACS) that occurs as a result of an allergic or anaphylactic reaction. Kounis syndrome can be induced by various medications including antibiotics, proton pump inhibitors, antihypertensive medications, corticosteroids, and antineoplastic medications. Additionally, cases of Kounis syndrome associated with lansoprazole and pantoprazole have been previously reported in the literature. In this report, we present a case of Kounis syndrome associated with omeprazole use, and discuss the need for a high index of suspicion as it is often underrecognised.
Asunto(s)
Anafilaxia , Síndrome de Kounis , Humanos , Anafilaxia/inducido químicamente , Anafilaxia/diagnóstico , Síndrome de Kounis/etiología , Síndrome de Kounis/complicaciones , Omeprazol/efectos adversos , Inhibidores de la Bomba de Protones/efectos adversosRESUMEN
An acute coronary syndrome due to mast-cell activation in the presence of an allergen is known as Kounis Syndrome (KS). This relatively new entity of KS is being increasingly recognized among allergists, cardiologists, and emergency physicians; however, it is not well-known among anesthesiologists. We report here, a case of type 2 KS due to antibiotic administration causing sudden perioperative cardiac arrest.
Asunto(s)
Síndrome Coronario Agudo , Anafilaxia , Paro Cardíaco , Síndrome de Kounis , Humanos , Síndrome de Kounis/complicaciones , Anafilaxia/inducido químicamente , Cefalosporinas , Síndrome Coronario Agudo/complicaciones , Paro Cardíaco/inducido químicamente , Paro Cardíaco/terapiaRESUMEN
Although not well known, Kounis syndrome represents 3.4 % of anaphylactic reactions and has a high level of mortality (7 %). Its main clinical presentation looks like an acute coronary syndrome. We report the case of a 61-year old patient who was admitted in the emergency department because of a malaise with loss of consciousness due to a Kounis syndrome that occurred after the ingestion of amoxycilline.
Le syndrome de Kounis représente une entité mal connue, bien que présent dans 3,4 % des réactions anaphylactiques avec une mortalité élevée de 7 %. Ses manifestations sont des symptômes mimant un syndrome coronarien aigu. Nous présentons ici le cas d'un patient de 61 ans admis au service des urgences pour un malaise avec perte de connaissance attribué à un syndrome de Kounis survenu dans les suites de la prise d'amoxycilline.
Asunto(s)
Síndrome Coronario Agudo , Anafilaxia , Síndrome de Kounis , Humanos , Persona de Mediana Edad , Anafilaxia/diagnóstico , Anafilaxia/etiología , Síndrome de Kounis/etiología , Síndrome de Kounis/complicaciones , Síndrome Coronario Agudo/inducido químicamente , Síndrome Coronario Agudo/diagnóstico , Servicio de Urgencia en Hospital , HospitalizaciónRESUMEN
Kounis syndrome (KS) is an acute coronary syndrome that occurs with allergic, hypersensitivity, anaphylactic, or anaphylactoid reactions associated with mast cell activation, and entails significant morbidity and mortality risks. We present four cases of acute coronary syndrome developing after insect bites, chemotherapy, and coronary stent implantation. Two patients were lost due to anaphylactic shock-related multiorgan failures and sudden cardiac death. Since a wide range of drugs, foods, environmental conditions, and disease states may be associated with KS, all physicians must be aware of the syndrome.
Asunto(s)
Síndrome Coronario Agudo , Anafilaxia , Síndrome de Kounis , Síndrome Coronario Agudo/complicaciones , Síndrome Coronario Agudo/diagnóstico , Síndrome Coronario Agudo/terapia , Anafilaxia/diagnóstico , Anafilaxia/etiología , Anafilaxia/terapia , Humanos , Síndrome de Kounis/complicaciones , Síndrome de Kounis/etiología , StentsRESUMEN
Kounis syndrome is an allergic acute coronary syndrome (ACS) characterised by coronary artery spasm, plaque erosion/rupture or stent thrombosis caused by mast cell and other interacting cell activation. Although intracoronary imaging modalities can detect those ACS mechanisms, Kounis syndrome due to plaque rupture has rarely been reported using intracoronary imaging. We present the case of a woman in her 70s who developed Kounis syndrome as a result of plaque rupture detected with optical coherence tomography (OCT). She had non-ST-segment elevation ACS as a result of anaphylaxis to cefazolin. Coronary angiography revealed severe stenosis in the left anterior descending artery; angiographically undetectable plaque rupture was detected using OCT. OCT also revealed intraplaque neovascularisation, suggesting that the culprit plaque had been vulnerable. OCT can aid in understanding the underlying mechanisms of Kounis syndrome.
Asunto(s)
Síndrome Coronario Agudo , Síndrome de Kounis , Placa Aterosclerótica , Femenino , Humanos , Síndrome de Kounis/complicaciones , Tomografía de Coherencia Óptica/métodos , Cefazolina , Placa Aterosclerótica/complicaciones , Placa Aterosclerótica/diagnóstico por imagen , Síndrome Coronario Agudo/diagnóstico por imagen , Síndrome Coronario Agudo/etiologíaRESUMEN
Kounis syndrome is the occurrence of acute coronary syndrome associated with mast cell and platelet activation in the setting of allergic or anaphylactic insults. Kounis syndrome has been previously reported following snake envenoming rarely, with or without antivenom therapy. We report a case of inferolateral ST elevation myocardial infarction 32 hours from a confirmed Russell's viper bite. He also had an anaphylactic reaction soon after antivenom. The absence of underlying atheromatous coronary artery disease during subsequent cardiac imaging was suggestive of a diagnosis of a type I variant of Kounis syndrome. Chest pain completely resolved by day 6 following initiation of standard treatment for acute coronary syndrome. Concurrence of allergic features and acute coronary syndrome in a snakebite patient following antivenom therapy should alert clinicians to the possibility of Kounis syndrome, which should be diagnosed with a high degree of clinical suspicion.
Asunto(s)
Síndrome Coronario Agudo , Anafilaxia , Daboia , Síndrome de Kounis , Mordeduras de Serpientes , Síndrome Coronario Agudo/complicaciones , Síndrome Coronario Agudo/tratamiento farmacológico , Anafilaxia/inducido químicamente , Animales , Antivenenos/uso terapéutico , Síndrome de Kounis/complicaciones , Síndrome de Kounis/etiología , Masculino , Mordeduras de Serpientes/complicaciones , Mordeduras de Serpientes/tratamiento farmacológico , Venenos de Víboras/toxicidadRESUMEN
Kounis syndrome (KS) is an acute coronary syndrome including coronary spasm, acute myocardial infarction, and stent thrombosis preceded by an anaphylactic, anaphylactoid, allergic, or hypersensitivity injury. In this case presentation, we discussed Type I and Type II KS. Case 1 was a 72-y-old man who presented to the emergency department with allergic symptoms and chest pain that developed after multiple bee stings. Electrocardiography showed ST depression in the lateral leads. Case 2 was a 42-y-old woman who presented to the emergency department with complaints of chest pain, dizziness, and presyncope that developed after multiple bee stings. Mobitz Type II Block with right bundle branch block was observed in 42 beats·min-1 in the electrocardiography. Both patients were first treated for allergic reaction. Although early percutaneous coronary intervention was performed for graft thrombosis in Case 1, a permanent pacemaker was inserted in Case 2. The patients were discharged without any complications. Increasing physician awareness towards the existence of KS can prevent fatal outcomes with early diagnosis and treatment.
Asunto(s)
Anafilaxia , Mordeduras y Picaduras de Insectos , Síndrome de Kounis , Trombosis , Animales , Abejas , Humanos , Síndrome de Kounis/etiología , Síndrome de Kounis/complicaciones , Mordeduras y Picaduras de Insectos/complicaciones , Anafilaxia/diagnóstico , Anafilaxia/etiología , Anafilaxia/terapia , Dolor en el Pecho/complicaciones , Arritmias Cardíacas/diagnóstico , Arritmias Cardíacas/etiología , Trombosis/complicacionesRESUMEN
Acute coronary syndrome (ACS) in the setting of an allergic/immunologic reaction is known as Kounis syndrome. It is an underdiagnosed and underrecognized disease entity. One must keep a high index of suspicions when managing a patient presenting with cardiac as well as allergic symptoms. There are 3 main variants to the syndrome. Treating the allergic reaction may alleviate the pain; however, ACS guidelines should be followed if cardiac ischemia is present.
Asunto(s)
Síndrome de Kounis/complicaciones , Síndrome de Kounis/inmunología , Humanos , Síndrome de Kounis/fisiopatologíaRESUMEN
Abstract 22-year-old male patient with no heart disease, who was given an ambulatory medication with analgesics due to an acute renal crisis. After the drug administration, the patient presented dyspnea, cyanosis, and hemoptysis. There was suspicion of anaphylactic shock, which was treated, but there was no improvement in the clinical condition. The patient was referred to the Intensive Care Unit, where tests were performed showing elevated cardiac enzymes and Immunoglobulin E and Computed Tomography of Thoracic revealed alveolar hemorrhage. He developed clinical worsening and died after sepsis. The final diagnosis was of kounis syndrome due to the hypersensitivity reaction to the analgesics introduced in the patient, generating an acute coronary syndrome (ACS). The purpose of this case report was to highlight a syndrome that is little reported because it is not part of the differential diagnosis routines of ACS, but it generates important complications.
Asunto(s)
Humanos , Masculino , Adulto , Adulto Joven , Síndrome Coronario Agudo/etiología , Síndrome de Kounis/diagnóstico , Corazón/efectos de los fármacos , Tramadol , Inmunoglobulinas , Biomarcadores , Sepsis/etiología , Diagnóstico Diferencial , Síndrome de Kounis/complicacionesRESUMEN
La anafilaxis es un síndrome multisistémico agudo grave que implica la liberación masiva del torrente sanguíneo de mastocitos y mediadores basófilos. Cuando las arterias coronarias son el objetivo principal, se puede sospechar el síndrome de Kounis o, más raramente, el llamado síndrome de Kounis cuando se trata de arterias cerebrales. Las lesiones isquémicas cerebrales pueden resultar de una presión arterial baja o de una acción mediadora proinflamatoria y/o vasoconstrictora directa en el sistema arterial cerebral. El diagnóstico es difícil en pacientes anestesiados. El tratamiento también es un reto, ya que la administración de adrenalina puede empeorar la isquemia. Presentamos un caso de síndrome de Kounis tipo II inducido por amoxicilina-ácido clavulánico bajo anestesia general, complicado con encefalopatía grave e irreversible de origen isquémico.(au)
Anaphylaxis is a severe acute multisystem syndrome involving massive mediator release from mast cells and basophils. Although the entire arterial system can be affected, when coronary arteries are the main targets, Kounis syndrome needs to be considered. Cerebral artery involvement has also been suggested in rarer MC-mediator release episodes; so-called Kounis-like syndrome. Cerebral ischaemic lesions can then result from low blood pressure or direct proinflammatory and/or vasoconstrictive mediator action in the cerebral arterial system. Diagnosis can be difficult in anaesthetised patients, as low blood pressure can have multiple causes. Treatment is also challenging, as administering adrenaline can worsen ischaemia. We report the first case of amoxicillin-clavulanic acid-induced type II Kounis syndrome under general anaesthesia, complicated with severe, irreversible and subsequently fatal encephalopathy of ischaemic origin. This case can contribute to awareness of less common Kounis syndrome manifestations, including severe cerebral involvement, or other anaphylactic reactions with atypical presentations.(AU)
Asunto(s)
Humanos , Masculino , Anciano , Síndrome de Kounis/complicaciones , Amoxicilina/administración & dosificación , Ácido Clavulánico/administración & dosificación , Lesiones Encefálicas , Anestesia , Epinefrina , Síndrome de Kounis/diagnóstico , Pacientes Internos , Examen Físico , AnestesiologíaRESUMEN
We herein describe the unusual case of irreversible diffuse hypoxic-ischemic encephalopathy secondary to type I Kounis syndrome. The patient survived and remained in a vegetative state after being mechanically ventilated in the intensive care unit for long. A brief review of the literature on mechanisms for KS-associated brain injury is also presented.
Asunto(s)
Encéfalo/diagnóstico por imagen , Hipoxia-Isquemia Encefálica/complicaciones , Hipoxia-Isquemia Encefálica/diagnóstico , Síndrome de Kounis/complicaciones , Encéfalo/patología , Encéfalo/fisiopatología , Femenino , Humanos , Persona de Mediana Edad , Estado Vegetativo Persistente/etiologíaRESUMEN
Acute coronary syndrome occurring during the course of a type I hypersensitivity reaction constitutes Kounis syndrome. We report a case of a 64-year-old man who presented with a non-ST elevation myocardial infarction and peripheral blood eosinophilia. He had rhinitis and constitutional symptoms for several days prior to presentation. Blood investigations revealed moderate eosinophilia and elevated IgE levels. A cardiac MRI showed generalised oedema with a subtle wall motion abnormality in basal inferior/inferolateral wall, and subendocardial high signal on late gadolinium enhancement suggesting a localised myocardial infarction. A coronary angiogram then revealed triple vessel disease. A diagnosis of Kounis syndrome was made. Within days of starting appropriate treatment, the patient's eosinophil count returned to normal with improvement of clinical picture.
Asunto(s)
Síndrome Coronario Agudo/etiología , Vasoespasmo Coronario/complicaciones , Hipersensibilidad Inmediata/complicaciones , Síndrome de Kounis/complicaciones , Angiografía Coronaria , Diagnóstico Diferencial , Electrocardiografía , Eosinofilia/etiología , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio sin Elevación del ST/etiologíaAsunto(s)
Medios de Contraste/efectos adversos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Yohexol/análogos & derivados , Síndrome de Kounis/complicaciones , Síndrome de Kounis/diagnóstico , Obstrucción del Flujo Ventricular Externo/inducido químicamente , Obstrucción del Flujo Ventricular Externo/diagnóstico , Obstrucción del Flujo Ventricular Externo/tratamiento farmacológico , Ecocardiografía/métodos , Femenino , Humanos , Yohexol/efectos adversos , Persona de Mediana Edad , Polonia , Resultado del TratamientoAsunto(s)
Anafilaxia/tratamiento farmacológico , Oclusión Coronaria/etiología , Síndrome de Kounis/complicaciones , Combinación Amoxicilina-Clavulanato de Potasio/efectos adversos , Combinación Amoxicilina-Clavulanato de Potasio/uso terapéutico , Anafilaxia/complicaciones , Dolor en el Pecho/etiología , Epinefrina/efectos adversos , Epinefrina/uso terapéutico , Humanos , Hidrocortisona/uso terapéutico , Síndrome de Kounis/fisiopatología , Masculino , Persona de Mediana Edad , Intervención Coronaria PercutáneaRESUMEN
BACKGROUND: The nationwide epidemiological data on Kounis Syndrome (KS), still remains indistinct in the United States (US) after it was first reported in 1991. METHODS: We assessed the prevalence of KS among patients primarily hospitalized for allergic/hypersensitivity/anaphylactic reactions. We then compared baseline demographics, comorbidities, and outcomes of KS with patients with only allergic/hypersensitivity/anaphylactic reactions using the National Inpatient Sample, 2007-2014. RESULTS: The cohort comprised of 235,420 patients primarily hospitalized with allergy/hypersensitivity/anaphylactic reactions. Of these, 2616 [1.1%; 0.2% unstable angina, 0.2% ST-elevation myocardial infarction & 0.7% non-ST-elevation myocardial infarction] patients experienced ACS and were identified as having KS. Patients with KS were older (mean 65.9⯱â¯14.1 vs. 57.2⯱â¯17.8â¯yrs), more often White (71.1% vs. 58.6%), male (46.4% vs. 39.9%) and Medicare enrollees (58.9% vs. 41.5%) admitted non-electively (96.8% vs. 95.3%) as compared to non-KS group (pâ¯<â¯0.001). The hospitalizations with KS demonstrated higher all-cause in-hospital mortality (7.0% vs. 0.4%, pâ¯<â¯0.001), prolonged hospitalization stay (mean 5.8⯱â¯6.0 vs. 3.0⯱â¯3.9â¯days, pâ¯<â¯0.001), higher hospitalization charges ($52,656 vs. $20,487, pâ¯<â¯0.001) and more frequent transfers to other facilities. The rates of stroke (1.0% vs. 0.2%), arrhythmias (30.4% vs. 12.4%), venous thromboembolism (1.6% vs. 1.0%), and diagnostic and therapeutic coronary interventions were also found to be significantly higher in patients with KS (pâ¯<â¯0.05). Patients with KS had increased odds of in-hospital mortality [unadjusted OR: 18.52; 95% CI: 15.74-21.80, pâ¯<â¯0.001 & adjusted OR: 9.74, 95% CI: 8.08-11.76, pâ¯<â¯0.001] compared to non-KS group. CONCLUSIONS: Overall US prevalence of KS among patients hospitalized for allergic/hypersensitivity/anaphylactic reactions is 1.1% with a subsequent all-cause inpatient mortality rate of 7.0%.
Asunto(s)
Síndrome de Kounis/epidemiología , Adolescente , Adulto , Anciano , Anafilaxia/complicaciones , Anafilaxia/epidemiología , Estudios Transversales , Femenino , Mortalidad Hospitalaria , Hospitalización , Humanos , Síndrome de Kounis/complicaciones , Masculino , Persona de Mediana Edad , Prevalencia , Estados Unidos/epidemiología , Adulto JovenRESUMEN
BACKGROUND: Kounis syndrome (allergic myocardial infarction) is the rare occurrence of systemic anaphylaxis with spontaneous electrocardiographic changes in response to an exogenous agent. Often the syndrome is caused by a drug reaction involving drugs such as non-steroidal anti-inflammatory drugs, antibiotics, or opioids. There are a few reported cases in the literature regarding diclofenac-induced Kounis syndrome, and little is known about the management of this clinical entity. CASE REPORT: A case of Kounis syndrome with ST-elevation myocardial infarction secondary to intramuscular (i.m.) diclofenac in a patient with prior coronary artery bypass graft surgery is described in this report. Additionally, we discuss the pathophysiology, clinical presentation, and management of this rare clinical entity. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: As i.m. diclofenac is a commonly used drug in the emergency department, we urge emergency physicians to be aware of the existence of this potentially fatal diclofenac-related adverse drug effect. If Kounis syndrome is suspected, the emergency physician is advised to balance the benefit of epinephrine for the treatment of anaphylaxis with the small theoretical risk of increasing coronary vasospasm.